ALNY vs DNUT · P/E 76, rev $1.29B vs rev $698.0M
Alnylam Pharmaceuticals Inc (ALNY) versus Krispy Kreme Inc (DNUT) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Krispy Kreme Inc (DNUT) is a grocery stores company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported DNUT revenue for 2026-06-28 was $698.0M. Net income was -$43.1M. Revenue was up 90.2% from 2026-03-29 to 2026-06-28. DNUT currently screens at market cap $605.1M.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. DNUT currently screens at market cap $605.1M.
Not investment advice. Open the ALNY and DNUT stock pages for the full models.
Not investment advice.